Wealthquest Corp bought a new position in shares of Avantor, Inc. (NYSE:AVTR – Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,100 shares of the company’s stock, valued at approximately $34,000.
A number of other hedge funds have also modified their holdings of AVTR. Smartleaf Asset Management LLC grew its position in Avantor by 106.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock valued at $34,000 after buying an additional 830 shares during the last quarter. Global Retirement Partners LLC grew its position in Avantor by 76.7% in the 4th quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock valued at $52,000 after buying an additional 1,067 shares during the last quarter. GAMMA Investing LLC grew its position in Avantor by 121.6% in the 1st quarter. GAMMA Investing LLC now owns 3,747 shares of the company’s stock valued at $61,000 after buying an additional 2,056 shares during the last quarter. Fifth Third Bancorp grew its position in Avantor by 52.0% in the 1st quarter. Fifth Third Bancorp now owns 3,972 shares of the company’s stock valued at $64,000 after buying an additional 1,359 shares during the last quarter. Finally, AlphaQuest LLC purchased a new position in Avantor in the 4th quarter valued at $65,000. 95.08% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at Avantor
In other news, Director Joseph R. Massaro bought 8,100 shares of the business’s stock in a transaction that occurred on Tuesday, April 29th. The stock was purchased at an average price of $12.30 per share, with a total value of $99,630.00. Following the purchase, the director now owns 35,038 shares of the company’s stock, valued at $430,967.40. This trade represents a 30.07% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Gregory L. Summe bought 30,000 shares of the business’s stock in a transaction that occurred on Friday, May 23rd. The stock was purchased at an average cost of $12.50 per share, with a total value of $375,000.00. Following the purchase, the director now directly owns 100,000 shares in the company, valued at $1,250,000. The trade was a 42.86% increase in their position. The disclosure for this purchase can be found here. Insiders bought 83,100 shares of company stock valued at $1,027,630 in the last 90 days. 1.20% of the stock is currently owned by insiders.
Analysts Set New Price Targets
View Our Latest Research Report on Avantor
Avantor Price Performance
Avantor stock opened at $13.61 on Thursday. The company has a market cap of $9.27 billion, a P/E ratio of 13.09, a price-to-earnings-growth ratio of 1.35 and a beta of 1.04. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.75 and a current ratio of 1.12. Avantor, Inc. has a one year low of $11.82 and a one year high of $28.00. The business has a fifty day moving average of $13.29 and a two-hundred day moving average of $17.02.
Avantor (NYSE:AVTR – Get Free Report) last released its quarterly earnings results on Friday, April 25th. The company reported $0.23 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.23. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.61 billion. Avantor had a return on equity of 11.93% and a net margin of 10.70%. The business’s revenue was down 5.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.22 EPS. As a group, analysts predict that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.
Avantor Company Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Further Reading
- Five stocks we like better than Avantor
- How to find penny stocks to invest and tradeĀ
- Top 3 Bank Stocks to Watch as Fed Rate Cuts Loom
- Business Services Stocks Investing
- Uber and Tesla Surge on Robotaxis, Analyst Touts Texas Rides
- There Are Different Types of Stock To Invest In
- ASML Keeps Buying Back Its Own StockāChasing Discount and Upside
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.